This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Martin Jenkins: Innovator in Drug Dosage Determination
Introduction
Martin Jenkins is a notable inventor based in Southampton, GB. He has made significant contributions to the field of drug administration through his innovative patent. His work focuses on improving the methods used to determine drug dosage regimens for patients.
Latest Patents
Jenkins holds a patent for "Drug dosage determination devices and methods." This invention relates to devices and methods for determining an administration regimen of a drug to a subject. The process involves computing the amount of drug to be administered per elemental period of time. Additionally, it evaluates combinations of at least two dosage forms that can be used to administer the drug against various criteria. The methods are particularly useful for selecting administration regimens for drugs available in multiple dosage forms, especially those administered routinely over prolonged periods, such as in the prophylaxis of hemophilia.
Career Highlights
Martin Jenkins is currently associated with Hoffmann-La Roche Inc., where he continues to contribute to advancements in pharmaceutical technology. His innovative approach to drug dosage determination has the potential to enhance patient care and treatment outcomes.
Collaborations
Jenkins has worked alongside notable colleagues, including Geraint Iwan Davies and David Elfant. Their collaborative efforts have furthered the development of effective drug administration methods.
Conclusion
Martin Jenkins is a pioneering inventor whose work in drug dosage determination is making a significant impact in the medical field. His innovative patent and collaboration with esteemed colleagues highlight his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
